OncoMed Pharmaceuticals Inc Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.65 | 5,510 | 119,286 | 1,947,308 | 2 M to 1.9 M (-0.28 %) |
Dec 30 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.62 | 9,902 | 214,048 | 1,952,818 | 2 M to 2 M (-0.50 %) |
Dec 30 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.65 | 2,195 | 47,516 | 1,962,720 | 2 M to 2 M (-0.11 %) |
Dec 23 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.71 | 20,654 | 448,310 | 1,964,915 | 2 M to 2 M (-1.04 %) |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | A | 21.18 | 35,000 | 741,300 | 35,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | A | 21.18 | 140,000 | 2,965,200 | 140,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
Dec 19 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 21.05 | 4,390 | 92,423 | 9,509 | 13.9 K to 9.5 K (-31.59 %) |
Dec 19 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 21.05 | 8,662 | 182,361 | 18,758 | 27.4 K to 18.8 K (-31.59 %) |
Dec 19 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 20.00 | 4,000 | 80,000 | 82,134 | 86.1 K to 82.1 K (-4.64 %) |
Dec 10 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.77 | 7,940 | 172,889 | 1,985,569 | 2 M to 2 M (-0.40 %) |
Dec 10 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.78 | 23,273 | 506,970 | 1,993,509 | 2 M to 2 M (-1.15 %) |
Dec 10 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.68 | 1,727 | 37,435 | 2,016,782 | 2 M to 2 M (-0.09 %) |
Dec 05 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 22.10 | 755 | 16,686 | 2,018,509 | 2 M to 2 M (-0.04 %) |
Dec 05 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 21.58 | 24,245 | 523,265 | 2,019,264 | 2 M to 2 M (-1.19 %) |
Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 48,277 | |
Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.19 | 4,000 | 84,752 | 20,000 | 24 K to 20 K (-16.67 %) |
Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |